Form 4: Inari Medical Director Catherine Szyman Disposes of Shares in Merger with Stryker

Director Catherine Szyman reports the disposition of Inari Medical shares and derivative securities following the merger with Stryker Corporation, where each share was converted to $80.00 in cash.

Summary

• Catherine Szyman, a director of Inari Medical, Inc., filed a Form 4 detailing changes in beneficial ownership of securities.
• The filing reflects transactions occurring on February 19, 2025, related to the merger between Inari Medical and Stryker Corporation.
• As a result of the merger, each share of Inari Medical common stock was converted into the right to receive $80.00 in cash.
• Szyman's holdings of 22,429 shares of common stock and 49,719 stock options were disposed of in the merger.
• The restricted stock units (RSUs) held by Szyman were also cancelled and converted into the right to receive cash based on the merger consideration.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as it reflects the completion of a merger, which typically provides shareholders with a defined cash value for their shares. The filing itself is a standard regulatory procedure.

Future Outlook

The document does not contain any specific forward-looking statements beyond the completion of the merger.

Industry Context

This announcement reflects a merger and acquisition activity within the medical device industry, where larger companies like Stryker acquire smaller, innovative firms like Inari Medical to expand their product portfolios and market reach.

Key Dates

Keywords

Form 4, Inari Medical, Stryker, Merger, Beneficial Ownership, Catherine Szyman, Securities, Disposition